PAPPA

PAPPA

Target · Secreted metalloproteinase

PAPPA Pappalysin-1 · pregnancy-associated plasma protein A

PAPPA (pappalysin 1, also known as PAPP-A or IGFBP-4ase) is a secreted metalloproteinase that cleaves insulin-like growth factor binding proteins and so releases bound IGF. It belongs to the peptidase M43B family and was originally named pregnancy-associated plasma protein A. Browse Assay Genie's current range of PAPPA research reagents below, or read on for the biology behind the target.

Secreted proteinIGFBP-cleaving metalloproteinaseLinked to diabetic nephropathy
1627 aa
Protein length
~181 kDa
Molecular weight
9q33.1
Gene locus
EC 3.4.24.79
Enzyme class
Target information

What is PAPPA (pappalysin 1)?

PAPPA is a metalloproteinase that specifically cleaves IGFBP-4 and IGFBP-5. Cleavage releases bound IGF, which can then dissociate from the binding protein and engage IGF receptors, activating the IGF pathway. The two substrates are regulated differently: cleavage of IGFBP-4 is dramatically enhanced by the presence of IGF, whereas cleavage of IGFBP-5 is slightly inhibited by it. This makes the enzyme a local regulator of IGF availability rather than a general protease.

The PAPPA gene encodes a secreted protein of the peptidase M43B family. HGNC places it in the pappalysin group, which also contains PAPPA2, and in the Sushi domain containing group. The enzyme carries the EC number 3.4.24.79, and the mouse ortholog is Pappa. Researchers working on this target often search under the aliases PAPP-A, PAPPA1, IGFBP-4ase, PAPA, ASBABP2 or DIPLA1.

According to the NCBI Gene summary, the PAPPA protein plays a role in bone formation, inflammation, wound healing and female fertility. Enhanced expression is associated with diabetic nephropathy in human patients, and the protein may promote tumour invasion and growth in various human cancers. These links between IGF signalling and disease keep PAPPA a frequent subject for studies of growth factor regulation, and it is commonly analysed alongside IGFBP-4, IGFBP-5 and IGF.

IGF pathway regulation

PAPPA cleaves IGFBP-4 and IGFBP-5 to free IGF, making it a point of control over IGF receptor activation.

Cancer biology

PAPPA may promote tumour invasion and growth in various human cancers, so it is studied in tumour progression.

Diabetic nephropathy

Enhanced PAPPA expression is associated with diabetic nephropathy in human patients, prompting research into its role in kidney disease.

Bone, healing and fertility

The protein contributes to bone formation, inflammation, wound healing and female fertility, which supports work across several physiological areas.

Background

PAPPA frequently asked questions

What does PAPPA do?

PAPPA is a secreted metalloproteinase that specifically cleaves IGFBP-4 and IGFBP-5, releasing bound IGF. The freed IGF can bind IGF receptors and activate the IGF pathway. IGF strongly enhances cleavage of IGFBP-4, while it slightly inhibits cleavage of IGFBP-5.

What other names is PAPPA known by?

The HGNC name is pappalysin 1, and UniProt lists Pappalysin-1. Earlier it was called pregnancy-associated plasma protein A. Aliases include PAPP-A, PAPPA1, IGFBP-4ase, PAPA, ASBABP2 and DIPLA1. Its related paralogue in the pappalysin group is PAPPA2.

Is PAPPA linked to disease, and is it conserved?

NCBI Gene reports that enhanced PAPPA expression is associated with diabetic nephropathy in humans and that it may promote tumour invasion and growth in various cancers. A mouse ortholog, Pappa, exists; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Pappalysin family members and related targets in IGF signalling with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13219; product specifications from Assay Genie datasheets.

PAPPA Product listing